Primecap Management CO Immunocore Holdings PLC Call Options Transaction History
Primecap Management CO
- $134 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMCR
# of Institutions
140Shares Held
40.8MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$202 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$186 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$140 Million2.42% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$61.8 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY1.52MShares$43.4 Million0.51% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.26B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...